AxelaRx Biosciences is a full service venture accelerator The Full Service Venture Accelerator, dedicated to bridging the gap between European and U.S. Life Sciences ventures. Their mission is to break down geographical barriers for Life Sciences ventures by providing them with the necessary support and resources. AxelaRx believes in the limitless potential of Life Sciences ventures and offers a membership and accelerator program designed to help these ventures establish, grow, and conduct business in the United States. The company's last investment was a Venture Round investment on 10 October 2019, with NextGen Ventures as the investors. With a primary focus on Health Care and Life Sciences, AxelaRx Biosciences is at the forefront of driving innovation and collaboration in the biotech industry.
No recent news or press coverage available for AxelaRx Biosciences.